iECURE Reports on Preliminary Clinical Response Data in First Infant Dosed with its in vivo Gene Editing Candidate ECUR-506
iECURE reported preliminary findings from the first infant dosed with its in vivo gene editing candidate ECUR-506.
Sahay AI Wins 1682 Venture Award for Most Promising AI-Driven Startups in Philadelphia
Sahay AI won the 1682 Venture Award, a pitch competition for early-stage AI-driven startups based in Philadelphia.
Penn Awarded NSF AIRFoundry Grant to Meld AI and RNA
The goal of the NSF AIRFoundry is to make cutting-edge RNA research accessible to the broader scientific community to empower scientists to tackle some of the world’s biggest challenges,
ViTToria Biotherapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of its VIPER-101 T-Cell Therapy
ViTToria has dosed the first patient in its Phase 1 clinical trial for VIPER-101.
āshibio Moves Forward with Clinical Trial
āshibio announced the dosing of the first participant in its Phase 2/3 clinical trial for its lead candidate, andecaliximab.
Cogwear Featured as a Startup to Watch in 2025
Cogwear was listed as one of PHL Inno’s Startups to Watch.
Interius Ranks in Top Ten of Capital Raises by Philadelphia Startups in 2024
Interius was recognized in the Philadelphia Business Journal’s “PHL Inno 2024 in Review” as one of the top Philadelphia-area startups raising capital last year.
Penn Spinout Gemma Therapeutics Raises $34 million to Develop Gene Therapies for Rare Diseases
Gemma Bio raised $34 million in a seed round led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital.
Stentix Awarded 2025 Y-Prize
Stentix won the 2025 Y-Prize competition after presenting their business plan for a bile duct stent that can be adjusted noninvasively to help patients maintain bile flow without further surgical inte
PCI’s 10th Anniversary Highlighted in Penn Today
PCI was featured as the lead story in the January 17th issue of Penn Today in recognition of its 10-year anniversary.